Celestica (CLS) Declines More Than Market: Some Information for Investors

Celestica (CLS) recently closed down 2.65%, underperforming the S&P 500, yet has surged 37.71% over the past month, significantly outpacing its sector. The company is forecasted for robust Q3 2025 results, with EPS projected at $1.45 (+39.42% YoY) and revenue at $3 billion (+19.99% YoY), contributing to strong full-year estimates. Despite holding a Zacks Rank #1 (Strong Buy) and operating in a top-ranked industry, CLS trades at a forward P/E of 45.84, representing a substantial premium over the industry average of 19.53.

Analysis

Celestica (CLS) exhibited a short-term divergence from its recent trend, closing down 2.65% against a mixed market, yet its performance over the past month has been exceptionally strong with a 37.71% gain, significantly outpacing both the Computer and Technology sector (+5.94%) and the S&P 500 (+2.57%). This robust appreciation is underpinned by powerful forward-looking fundamentals. Consensus estimates for the upcoming quarter project a 39.42% year-over-year increase in EPS to $1.45 and a 19.99% rise in revenue to $3 billion. The full-year outlook is similarly bullish, with forecasts pointing to a 43.04% increase in earnings and a 20.61% increase in revenue. This positive sentiment is reinforced by a Zacks Rank of #1 (Strong Buy) and its position in the top 8% of industries. However, this optimism is reflected in the stock's valuation; its forward P/E ratio of 45.84 represents a substantial premium to the industry average of 19.53, suggesting high expectations are already priced into the stock.

Key Decisions for Investors

• Investors should consider that while the strong growth outlook, evidenced by a +43% YoY full-year EPS forecast and a #1 Zacks Rank, presents a compelling bull case, the stock's premium forward P/E of 45.84 indicates that these high expectations are already priced in.
• Given the stock's sharp 37.71% rise in the last month, the recent daily pullback could be a signal of profit-taking, and current holders should monitor for any negative revisions to analyst estimates ahead of the October 27th earnings report, as the high valuation offers little margin for error.
• Potential investors should weigh the company's strong fundamental momentum and top-tier industry ranking against the valuation risk, which could make the stock susceptible to a significant correction if it fails to meet its aggressive growth targets or if broader market sentiment sours.